Log In
Print this Print this

RAF265 (formerly CHIR-265)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionSmall molecule inhibitor of the Raf kinases
Molecular Target CRAF (RAF1)
Mechanism of ActionRaf inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today